GeneDx Holdings (WGSWW) Net Cash Flow (2020 - 2026)

GeneDx Holdings (WGSWW) has 7 years of Net Cash Flow data on file, last reported at -$11.1 million in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$11.1 million, down 176.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.8 million (down 136.04% YoY), and the FY2025 annual result was $19.8 million, up 236.78% from the prior year.
• Net Cash Flow declined to -$11.1 million in Q1 2026 per WGSWW's latest filing, from $9.0 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $76.6 million in Q1 2023 and troughed at -$93.3 million in Q3 2022.
• A 5-year average of -$18.0 million and a median of -$16.0 million in 2024 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2023 and 2025: Net Cash Flow sank 239.85% in 2023, then jumped 1101.76% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$67.4 million in 2022, then surged by 118.36% to $12.4 million in 2023, then jumped by 120.67% to $27.3 million in 2024, then tumbled by 66.94% to $9.0 million in 2025, then plunged by 222.61% to -$11.1 million in 2026.
• Business Quant data shows WGSWW's Net Cash Flow at -$11.1 million in Q1 2026, $9.0 million in Q4 2025, and $21.8 million in Q3 2025.